APA

Warshaw E. M., Wohlhuter R. J., Liu A., Zeller S. A., Wenner R. A., Bowers S., Schultz J. C., Katz H. I., McCormick C. L. & Parneix-Spake A. (20070731). Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. : Journal of the American Academy of Dermatology.

Chicago

Warshaw Erin M, Wohlhuter Ross Jon, Liu An, Zeller Sarah A, Wenner Rachel A, Bowers Sacharitha, Schultz Julie C, Katz H Irving, McCormick Calogera L and Parneix-Spake Anne. 20070731. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. : Journal of the American Academy of Dermatology.

Harvard

Warshaw E. M., Wohlhuter R. J., Liu A., Zeller S. A., Wenner R. A., Bowers S., Schultz J. C., Katz H. I., McCormick C. L. and Parneix-Spake A. (20070731). Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. : Journal of the American Academy of Dermatology.

MLA

Warshaw Erin M, Wohlhuter Ross Jon, Liu An, Zeller Sarah A, Wenner Rachel A, Bowers Sacharitha, Schultz Julie C, Katz H Irving, McCormick Calogera L and Parneix-Spake Anne. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. : Journal of the American Academy of Dermatology. 20070731.